NO960965L - Genet Grb3-3 med varianter derav samt deres anvendelse - Google Patents

Genet Grb3-3 med varianter derav samt deres anvendelse

Info

Publication number
NO960965L
NO960965L NO960965A NO960965A NO960965L NO 960965 L NO960965 L NO 960965L NO 960965 A NO960965 A NO 960965A NO 960965 A NO960965 A NO 960965A NO 960965 L NO960965 L NO 960965L
Authority
NO
Norway
Prior art keywords
grb3
variants
gene
protein
sequences
Prior art date
Application number
NO960965A
Other languages
English (en)
Other versions
NO960965D0 (no
NO319144B1 (no
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO960965L publication Critical patent/NO960965L/no
Publication of NO960965D0 publication Critical patent/NO960965D0/no
Publication of NO319144B1 publication Critical patent/NO319144B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19960965A 1993-09-15 1996-03-08 Nukleotidsekvens og dens anvendelse, vektor omfattende sekvensen samt farmasoytisk preparat omfattende vektoren. NO319144B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9310971A FR2710074B1 (fr) 1993-09-15 1993-09-15 Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr) 1993-09-15 1994-05-09 Gene grb3-3, ses variants et leurs utilisations

Publications (3)

Publication Number Publication Date
NO960965L true NO960965L (no) 1996-03-08
NO960965D0 NO960965D0 (no) 1996-03-08
NO319144B1 NO319144B1 (no) 2005-06-27

Family

ID=9450882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19960965A NO319144B1 (no) 1993-09-15 1996-03-08 Nukleotidsekvens og dens anvendelse, vektor omfattende sekvensen samt farmasoytisk preparat omfattende vektoren.

Country Status (27)

Country Link
US (2) US5831048A (no)
EP (1) EP0719328B1 (no)
JP (1) JP3794697B2 (no)
KR (1) KR100330477B1 (no)
CN (1) CN1098930C (no)
AT (1) ATE196926T1 (no)
AU (1) AU698819B2 (no)
BR (1) BR9407693A (no)
CA (1) CA2169938A1 (no)
CZ (1) CZ288882B6 (no)
DE (1) DE69426121T2 (no)
DK (1) DK0719328T3 (no)
ES (1) ES2152313T3 (no)
FI (1) FI120499B (no)
FR (1) FR2710074B1 (no)
GR (1) GR3034600T3 (no)
HU (1) HU221516B (no)
IL (2) IL110942A (no)
NO (1) NO319144B1 (no)
NZ (1) NZ266162A (no)
PL (1) PL178402B1 (no)
PT (1) PT719328E (no)
RU (1) RU2159815C2 (no)
SK (1) SK281123B6 (no)
UA (1) UA46715C2 (no)
WO (1) WO1995007981A1 (no)
ZA (1) ZA947059B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
AU6342696A (en) * 1996-06-27 1998-01-14 Biogen, Inc. The caip-like gene family
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
KR20080023768A (ko) 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
CA2471967A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer
CN121476598A (zh) * 2025-11-03 2026-02-06 昆明理工大学 Grb2基因表达抑制剂在制备增强肿瘤细胞药物敏感性制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920151A1 (en) * 1991-01-18 1992-07-29 Univ New York A novel expression-cloning method for identifying target¹proteins for receptor tyrosine kinases and novel human grb¹proteins
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
BR9407693A (pt) 1997-02-04
WO1995007981A1 (fr) 1995-03-23
ATE196926T1 (de) 2000-10-15
AU6724794A (en) 1995-04-03
HUT74273A (en) 1996-11-28
ZA947059B (en) 1995-05-18
HU9600668D0 (en) 1996-05-28
USRE37952E1 (en) 2002-12-31
KR100330477B1 (ko) 2002-12-02
CA2169938A1 (fr) 1995-03-23
PL313445A1 (en) 1996-07-08
EP0719328A1 (fr) 1996-07-03
NO960965D0 (no) 1996-03-08
FI120499B (fi) 2009-11-13
UA46715C2 (uk) 2002-06-17
SK281123B6 (sk) 2000-12-11
CZ288882B6 (cs) 2001-09-12
DE69426121T2 (de) 2001-05-31
IL110942A (en) 2001-12-23
JP3794697B2 (ja) 2006-07-05
CN1098930C (zh) 2003-01-15
EP0719328B1 (fr) 2000-10-11
NO319144B1 (no) 2005-06-27
PL178402B1 (pl) 2000-04-28
FI961202L (fi) 1996-03-14
SK34596A3 (en) 1996-07-03
AU698819B2 (en) 1998-11-05
HU221516B (hu) 2002-11-28
GR3034600T3 (en) 2001-01-31
JPH09502357A (ja) 1997-03-11
DK0719328T3 (da) 2000-11-13
IL126756A (en) 2006-06-11
FR2710074A1 (fr) 1995-03-24
CZ75896A3 (en) 1996-06-12
RU2159815C2 (ru) 2000-11-27
US5831048A (en) 1998-11-03
PT719328E (pt) 2001-02-28
NZ266162A (en) 1997-11-24
IL110942A0 (en) 1994-11-28
ES2152313T3 (es) 2001-02-01
FR2710074B1 (fr) 1995-12-08
DE69426121D1 (de) 2000-11-16
CN1133064A (zh) 1996-10-09
FI961202A0 (fi) 1996-03-14

Similar Documents

Publication Publication Date Title
NO960965D0 (no) Genet Grb3-3 med varianter derav samt deres anvendelse
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
PT1548032E (pt) Péptidos kdr e vacinas que os contêm
DK265685D0 (da) Thrombininhibitorer samt deres fremstilling og anvendelse
ATE331034T1 (de) Samenstrenung resistenz
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DK289688A (da) Ekspression af proapolipoprotein a-i.
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE384787T1 (de) Tripeptidyl-aminopeptidase
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
GB9215232D0 (en) Vaccines
DE60043470D1 (de) Pflanzliche Defensine
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
HUP0400915A2 (hu) Növényi reprodukciós proteinek
GB9720038D0 (en) Control
WO2001014519A3 (en) Methods and compositions for regulating developmental identity
CA2419038A1 (en) Nucleic acid and protein increasing expression levels under salt stress
EP1221487A3 (en) Polynucleotide molecules encoding neospora proteins
AP2961A (en) An isolated nucleotide sequence and transgenic organism containing said sequence.
CO5400145A1 (es) Proteina asociada con enfermedad
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees